Activation of the negative co-stimulatory molecules like cytotoxic T-lymphocyte- associated antigen 4 (CTLA4), LAG3, and TIGIT are associated with the progression of HCC (Moreno-Cubero and Larrubia, 2016; Yu et al., 2021). Here, CTLA4 is linked to hepatocellular carcinoma.